Trypanosoma cruzi in donors who go to the “Dr. Julio Garcia Alvarez” Blood Bank of the Dr. Luis Razetti Hospital, in the Barinas city, Venezuela
Abstract
Trypanosoma cruzi is the causative agent of Chagas disease; this is considered one of the main parasitosis in Latin America. Blood transfusions occupy the second place of transmission of this parasite, after vector transmission and usually occur in urban areas through infected donors from endemic rural areas, generally asymptomatic and ignorant of their condition. In Venezuela, Barinas state is recognized as an important endemic area of T. cruzi transmission. In this sense, was to evaluate parasitological and serological techniques in donors who go to the “Dr. Julio Garcia Alvarez” Blood Bank in the Barinas city. To this end, 240 blood samples were collected from an equal number of donors and were assessed with fresh examination techniques, capillary microcentrifugation, colored smears, and ELISA anti-T. cruzi IgG. In none of the samples circulating parasites were observed, while 3 donors resulted positive with ELISA anti-T. cruzi IgG (1.25% seroprevalence). Direct parasitological tests were not effective for the determination of T. cruzi because there was no evidence of blood trypomastigotes in any of the cases studied.References
Añez N, Crisante G, Rojas A, Dávila D. Brote de Enfermedad de Chagas agudo por posible transmisión oral en Mérida, Venezuela. Bol Malariol Salud Amb. 2013;53(1):1-11. Disponible en: https://www.researchgate.net/publication/262590484_Brote_de_enfermedad_de_Chagas_agudo_de_posible_transmision_oral_en_Merida_Venezuela
Incani R. Parasitología. 2da ed. Valencia: Ediciones Delforn C.A; 2000. p. 145-157.
Díaz Bello Z, Zavala Jaspe R, Díaz Villalobos M, Mauriello L, Maekelt A, Alarcón B. Diagnóstico confirmatorio de anticuerpos anti-Trypanosoma cruzi en donantes referidos por bancos de sangre en Venezuela. Invest Clin. 2008;49(2):141-150. Disponible en: http://www.scielo.org.ve/scielo.php?script=sci_arttext&pid=S0535-51332008000200003. PMID: 18717262
Berrizbeitia M, González F, Ndao M, Ward B, Rodríguez J, Cortéz Y. Seroprevalencia de infección por Trypanosoma cruzi en bancos de sangre públicos del oriente de Venezuela. Rev Soc Venez Microbiol. 2014;34(1):43-48. Disponible en: https://www.scielosp.org/article/ssm/content/raw/?resource_ssm_path=/media/assets/csp/v33n10/1678-4464-csp-33-10-e00050216.pdf
Niederhauser C, Gottschalk J, Tinguely C. Selective testing of at-risk blood donors for Trypanosoma cruzi and Plasmodium spp. in Switzerland. Transfus Med Hemother 2016;43(3):169-176. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924468/. DOI: 10.1159/000446218. PMID: 27403088. PMCID. PMC4924468.
Mandell G, Beneett J, Dolin R. Enfermedades infecciosas: Principios y prácticas 7ma ed. Barcelona: Elsevier; 2012. p. 3478.
Storino R, Milei J. Enfermedad de Chagas. Buenos Aires: Editorial Mosby; 1994. p. 279-287.
Coura J. The main sceneries of Chagas disease transmission. The vectors, blood and oral transmissions - A comprehensive review. Mem Inst Oswaldo Cruz. 2015;110(3):277-282. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489464/pdf/0074-0276-mioc-110-3-0277.pdf. DOI: 10.1590/0074-0276140362. PMID: 25466622. PMCID: PMC4489464.
OMS. 2016. Enfermedad de Chagas. Disponible en línea en http://www.who.int/topics/chagas_disease/es/. [Acceso 06.12.2016].
Faust E, Russel P, Clifton R. Parasitología clínica. Barcelona: Salvat Editores; 1974. p. 887.
Botero D, Restrepo M. Parasitosis humanas. 5ta ed. Medellín: Corporación para investigaciones biológicas (CIB); 2012. p. 287-292.
GrupoBios S.A. 2008. Test ELISA Chagas III. Santiago. Chile. Disponible en línea en: http://www.annardx.com/productos/images/productos/diagnostica/infecciosas/Test-Chagas-III.pdf. [Acceso 07.03.2017].
Silva SM, Oliveira MB, Martinez EZ. Distribution of serological screening markers at a large hematology and hemotherapy center in Minas Gerais, Southeastern Brazil. Rev Bras Hematol Hemoter. 2016;38(3):206-213. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/?term=Distribution+of+serological+screening+markers+at+a+large+hematology+and+hemotherapy+center+in+Minas+Gerais%2C+Southeastern+Brazil. DOI: 10.1016/j.bjhh.2016.05.005. PMID: 27521858. PMCID: PMC4997899.
Werner B, Heitmann I, Jercic M, Jofré L, Muñoz P, Noemí I, et al. Parte III. Enfermedad de Chagas en donantes de banco de sangre. Rev Chil Infect. 2008; 25(4):285-288. Disponible en: https://scielo.conicyt.cl/pdf/rci/v25n4/art07.pdf. DOI: http://dx.doi.org/10.4067/S0716-10182008000400007. PMID: 18769776.
Monsalve Perdigón Y, Mujica Delgado M, Silva Escalona R, Mirolo Perozo M, Álvarez C, Rodríguez Bonfante C, et al. Importancia del diagnóstico de anticuerpos para Trypanosoma cruzi en donantes voluntarios mediante metodología recomendada por la OMS comparada con la utilizada en banco de sangre “Dr. José Jesús Boada Boada” y su relación con antecedentes epidemiológicos para Enfermedad de Chagas. Venezuela. Bol Med Post Uni Cen Lisandro Alvarado Abr-jun. 2004;20(2):1-5. Disponible en: http://bibvirtual.ucla.edu.ve/db/psm_ucla/edocs/bm/BM2002/BM200210.pdf
Añez N, Carrasco H, Parada H, Crisante G, Rojas A, González N, et al. Acute Chagas disease in western Venezuela: a clinical, seroparasitologic, and epidemiologic study. Venezuela. Am J Trop Med Hyg. 1999;60(2):215-222. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/10072139. DOI: 10.4269/ajtmh.1999.60.215. PMID: 10072139.
Flores Chávez M, de Fuentes I, Gárate T, Cañavate C. Diagnóstico de laboratorio de la enfermedad de Chagas importada. Enferm Infecc Microbiol Clin 2007;3(25 Supl):29-37. Disponible en: https://www.seimc.org/contenidos/ccs/revisionestematicas/parasitologia/ccs-2006-parasitologia1.pdf.
Beltrán M, Herrera A, Flórez A, Berrío M, Bermúdez M. Detección de anticuerpos contra Trypanosoma cruzi en pacientes multitransfundidos, Colombia. Biomédica. 2017;37(3):361-367. Disponible en: https://www.revistabiomedica.org/index.php/biomedica/article/view/3177. DOI: 10.7705/biomedica.v37i3.3177. PMID: 28968013.
Copyright (c) 2019 Maria del Carmen Barrueta, Carlos Alberto González, Ana María Bolivar
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Kasmera journal is registered under a Creative Commons an Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0), available at: https://creativecommons.org/licenses/by-nc-sa/4.0/deed.en; which guarantees the freedom to share-copy and redistribute the material in any medium or format and adapt-remix, transform and build from the material, provided that the name of the authors, the Department of Infectious and Tropical Diseases, Zulia´s University and Kasmera Journal, you must also provide a link to the original document and indicate if changes have been made.
The Department of Infectious and Tropical Diseases, University of Zulia and Kasmera Journal do not retain the rights to published manuscript and the contents are the sole responsibility of the authors, who retain their moral, intellectual, privacy and publicity rights. The guarantee on the intervention of the manuscript (revision, correction of style, translation, layout) and its subsequent dissemination is granted through a license of use and not through a transfer of rights, which represents the Kasmera Journal and Department Infectious Diseases, University of Zulia are exempt from any liability that may arise from ethical misconduct by the authors.
Kasmera is considered a green SHERPA/RoMEO journal, that is, it allows self-archiving of both the pre-print (draft of a manuscript) and the post-print (the corrected and peer-reviewed version) and even the final version (layout as it will be published in the journal) both in personal repositories and in institutional and databases.